Annual ROE
160.08%
+213.94%+397.22%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual return on equity is 160.08%, with the most recent change of +213.94% (+397.22%) on December 31, 2023.
- During the last 3 years, ACOR annual ROE has risen by +196.38% (+540.99%).
Performance
ACOR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
485.80%
+1392.41%+153.58%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly return on equity is 485.80%, with the most recent change of +1392.41% (+153.58%) on March 31, 2024.
- Over the past year, ACOR quarterly ROE has increased by +548.83% (+870.74%).
Performance
ACOR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ACOR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +397.2% | +870.7% |
| 3 y3 years | +541.0% | +1140.5% |
| 5 y5 years | +2590.4% | +10000.0% |
ACOR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -133.6% | at high | -286.6% |
| 5 y | 5-year | at high | -137.0% | at high | -286.6% |
| alltime | all time | at high | -321.7% | at high | -353.7% |
Acorda Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | 485.80%(-153.6%) |
| Dec 2023 | 160.08%(-397.2%) | -906.61%(+4142.4%) |
| Sep 2023 | - | -21.37%(-17.8%) |
| Jun 2023 | - | -26.01%(-58.7%) |
| Mar 2023 | - | -63.03%(+2.5%) |
| Dec 2022 | -53.86%(+0.8%) | -61.49%(-29.3%) |
| Sep 2022 | - | -87.03%(+5.7%) |
| Jun 2022 | - | -82.35%(+45.6%) |
| Mar 2022 | - | -56.57%(+3.4%) |
| Dec 2021 | -53.43%(+47.2%) | -54.69%(-26.9%) |
| Sep 2021 | - | -74.79%(+40.4%) |
| Jun 2021 | - | -53.27%(+14.1%) |
| Mar 2021 | - | -46.69%(+36.9%) |
| Dec 2020 | -36.30%(-38.6%) | -34.11%(-308.8%) |
| Sep 2020 | - | 16.34%(-125.6%) |
| Jun 2020 | - | -63.93%(+10.9%) |
| Mar 2020 | - | -57.66%(-2.2%) |
| Dec 2019 | -59.16%(-1094.3%) | -58.94%(-6.7%) |
| Sep 2019 | - | -63.19%(+366.0%) |
| Jun 2019 | - | -13.56%(+1283.7%) |
| Mar 2019 | - | -0.98%(-116.8%) |
| Dec 2018 | 5.95%(-115.8%) | 5.83%(-123.6%) |
| Sep 2018 | - | -24.70%(-4.3%) |
| Jun 2018 | - | -25.81%(-24.0%) |
| Mar 2018 | - | -33.97%(-1.3%) |
| Dec 2017 | -37.56%(+587.9%) | -34.42%(+319.8%) |
| Sep 2017 | - | -8.20%(+29.1%) |
| Jun 2017 | - | -6.35%(-19.2%) |
| Mar 2017 | - | -7.86%(+49.7%) |
| Dec 2016 | -5.46%(-382.9%) | -5.25%(+50.9%) |
| Sep 2016 | - | -3.48%(+282.4%) |
| Jun 2016 | - | -0.91%(-139.7%) |
| Mar 2016 | - | 2.29%(+16.8%) |
| Dec 2015 | 1.93%(-46.4%) | 1.96%(+390.0%) |
| Sep 2015 | - | 0.40%(-79.1%) |
| Jun 2015 | - | 1.91%(-29.5%) |
| Mar 2015 | - | 2.71%(-24.7%) |
| Dec 2014 | 3.60% | 3.60%(-28.4%) |
| Sep 2014 | - | 5.03%(+17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | 4.29%(-0.7%) |
| Mar 2014 | - | 4.32%(+7.7%) |
| Dec 2013 | 3.98%(-92.4%) | 4.01%(-89.6%) |
| Sep 2013 | - | 38.62%(-11.9%) |
| Jun 2013 | - | 43.84%(-11.6%) |
| Mar 2013 | - | 49.59%(-17.7%) |
| Dec 2012 | 52.43%(+205.4%) | 60.28%(+277.7%) |
| Sep 2012 | - | 15.96%(-27.1%) |
| Jun 2012 | - | 21.90%(+4.0%) |
| Mar 2012 | - | 21.06%(+18.5%) |
| Dec 2011 | 17.17%(-310.4%) | 17.77%(+31.4%) |
| Sep 2011 | - | 13.52%(+31.0%) |
| Jun 2011 | - | 10.32%(+65.4%) |
| Mar 2011 | - | 6.24%(-171.8%) |
| Dec 2010 | -8.16%(-83.3%) | -8.69%(-68.7%) |
| Sep 2010 | - | -27.79%(-43.3%) |
| Jun 2010 | - | -49.04%(-11.4%) |
| Mar 2010 | - | -55.33%(+13.9%) |
| Dec 2009 | -48.73%(-11.3%) | -48.57%(+13.1%) |
| Sep 2009 | - | -42.95%(-3.9%) |
| Jun 2009 | - | -44.71%(+0.6%) |
| Mar 2009 | - | -44.44%(-12.2%) |
| Dec 2008 | -54.95%(-40.6%) | -50.64%(-10.1%) |
| Sep 2008 | - | -56.35%(-12.2%) |
| Jun 2008 | - | -64.16%(-4.3%) |
| Mar 2008 | - | -67.05%(-14.8%) |
| Dec 2007 | -92.51%(-28.1%) | -78.66%(-14.6%) |
| Sep 2007 | - | -92.16%(-43.1%) |
| Jun 2007 | - | -161.85%(-71.9%) |
| Mar 2007 | - | -575.79%(-53.3%) |
| Dec 2006 | -128.66%(-522.0%) | -1232.69%(-1577.3%) |
| Sep 2006 | - | 83.44%(+71.2%) |
| Jun 2006 | - | 48.73%(+47.9%) |
| Mar 2006 | - | 32.94%(+110.9%) |
| Dec 2005 | 30.49%(-58.7%) | 15.62%(+112.2%) |
| Sep 2005 | - | 7.36%(-105.5%) |
| Dec 2004 | 73.87%(-120.8%) | - |
| Dec 2003 | -354.82%(+387.1%) | - |
| Sep 2003 | - | -132.83% |
| Jun 2003 | -72.84% | - |
FAQ
- What is Acorda Therapeutics annual return on equity?
- What is the all time high annual ROE for Acorda Therapeutics?
- What is Acorda Therapeutics annual ROE year-on-year change?
- What is Acorda Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly ROE year-on-year change?
What is Acorda Therapeutics annual return on equity?
The current annual ROE of ACOR is 160.08%
What is the all time high annual ROE for Acorda Therapeutics?
Acorda Therapeutics all-time high annual return on equity is 160.08%
What is Acorda Therapeutics annual ROE year-on-year change?
Over the past year, ACOR annual return on equity has changed by +213.94% (+397.22%)
What is Acorda Therapeutics quarterly return on equity?
The current quarterly ROE of ACOR is 485.80%
What is the all time high quarterly ROE for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly return on equity is 485.80%
What is Acorda Therapeutics quarterly ROE year-on-year change?
Over the past year, ACOR quarterly return on equity has changed by +548.83% (+870.74%)